A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer by Katia Grillone, Giulio Caridà, Francesco Luciano, Alessia Cordua, Maria Teresa Di Martino, Pierosandro Tagliaferri, Pierfrancesco Tassone

Subjects: “…RNA-therapeutics…”
Get full text

Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-... by Pierfrancesco Tassone, Maria Teresa Di Martino, Mariamena Arbitrio, Lucia Fiorillo, Nicoletta Staropoli, Domenico Ciliberto, Alessia Cordua, Francesca Scionti, Bernardo Bertucci, Angela Salvino, Mariangela Lopreiato, Fredrik Thunarf, Onofrio Cuomo, Maria Cristina Zito, Maria Rosanna De Fina, Amelia Brescia, Simona Gualtieri, Caterina Riillo, Francesco Manti, Daniele Caracciolo, Vito Barbieri, Eugenio Donato Di Paola, Adele Emanuela Di Francesco, Pierosandro Tagliaferri

Subjects: “…miRNA therapeutics…”
Get full text

Tailoring Design of Nanomaterials and Systems to Individualize Patient Treatments by Marija Buljan, Peter Wick

Subjects: Get full text

The Limitless Future of RNA Therapeutics by Tulsi Ram Damase, Roman Sukhovershin, Christian Boada, Francesca Taraballi, Francesca Taraballi, Roderic I. Pettigrew, John P. Cooke

Subjects: “…RNA therapeutics…”
Get full text

Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndrome by Dongwon Lee, Wu Chen, Heet Naresh Kaku, Xinming Zhuo, Eugene S Chao, Armand Soriano, Allen Kuncheria, Stephanie Flores, Joo Hyun Kim, Armando Rivera, Frank Rigo, Paymaan Jafar-nejad, Arthur L Beaudet, Matthew S Caudill, Mingshan Xue

Subjects: Get full text

How late is too late for treatment? by Lawrence T Reiter

Subjects: Get full text

Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats by Maria Teresa Di Martino, Mariamena Arbitrio, Daniele Caracciolo, Francesca Scionti, Pierosandro Tagliaferri, Pierfrancesco Tassone

Subjects: Get full text

Is miR therapeutic targeting still a miRage? by Elena Levantini

Subjects: “…rna therapeutics…”
Get full text

Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application by Tatsuo Adachi, Yoshikazu Nakamura

Subjects: Get full text

Delivery of oligonucleotide‐based therapeutics: challenges and opportunities by Suzan M Hammond, Annemieke Aartsma‐Rus, Sandra Alves, Sven E Borgos, Ronald A M Buijsen, Rob W J Collin, Giuseppina Covello, Michela A Denti, Lourdes R Desviat, Lucía Echevarría, Camilla Foged, Gisela Gaina, Alejandro Garanto, Aurelie T Goyenvalle, Magdalena Guzowska, Irina Holodnuka, David R Jones, Sabine Krause, Taavi Lehto, Marisol Montolio, Willeke Van Roon‐Mom, Virginia Arechavala‐Gomeza

Subjects: Get full text

Assembling the RNA therapeutics toolbox by Teng Mona, Xia Ziting Judy, Lo Nicholas, Daud Kashif, He Housheng Hansen

Subjects: “…rna therapeutics…”
Get full text

A microRNA signature that correlates with cognition and is a target against cognitive decline by Md Rezaul Islam, Lalit Kaurani, Tea Berulava, Urs Heilbronner, Monika Budde, Tonatiuh Pena Centeno, Vakthang Elerdashvili, Maria‐Patapia Zafieriou, Eva Benito, Sinem M Sertel, Maria Goldberg, Fanny Senner, Janos L Kalman, Susanne Burkhardt, Anne Sophie Oepen, Mohammad Sadman Sakib, Cemil Kerimoglu, Oliver Wirths, Heike Bickeböller, Claudia Bartels, Frederic Brosseron, Katharina Buerger, Nicoleta‐Carmen Cosma, Klaus Fliessbach, Michael T. Heneka, Daniel Janowitz, Ingo Kilimann, Luca Kleinedam, Christoph Laske, Coraline D Metzger, Matthias H Munk, Robert Perneczky, Oliver Peters, Josef Priller, Boris S. Rauchmann, Nina Roy, Anja Schneider, Annika Spottke, Eike J Spruth, Stefan Teipel, Maike Tscheuschler, Michael Wagner, Jens Wiltfang, Emrah Düzel, Frank Jessen, Delcode Study Group, Silvio O Rizzoli, Wolfram‐Hubertus Zimmermann, Thomas G Schulze, Peter Falkai, Farahnaz Sananbenesi, Andre Fischer

Subjects: Get full text

RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs by Sarah Bajan, Gyorgy Hutvagner

Subjects: Get full text

ACE mRNA (Additional Chimeric Element incorporated IVT mRNA) for Enhancing Protein Expression by Modulating Immunogenicity by Sora Son, Minsa Park, Jin Kim, Kyuri Lee

Subjects: Get full text

PEGylation of mRNA by Hybridization of Complementary PEG-RNA Oligonucleotides Stabilizes mRNA without Using Cationic Materials by Naoto Yoshinaga, Mitsuru Naito, Yoshihiro Tachihara, Eger Boonstra, Kensuke Osada, Horacio Cabral, Satoshi Uchida

Subjects: “…mRNA therapeutics…”
Get full text

Micro-minicircle Gene Therapy: Implications of Size on Fermentation, Complexation, Shearing Resistance, and Expression by Sofia Stenler, Oscar PB Wiklander, Maria Badal-Tejedor, Janne Turunen, Joel Z Nordin, David Hallengärd, Britta Wahren, Samir EL Andaloussi, Mark W Rutland, CI Edvard Smith, Karin E Lundin, Pontus Blomberg

Subjects: Get full text

Peptide-modified PAMAM-based bone-targeting RNA delivery system by Suryaji Patil, Yong-Guang Gao, Airong Qian

Subjects: Get full text

Targeted Nanocarrier Delivery of RNA Therapeutics to Control HIV Infection by Esinam E. Agbosu, Scott Ledger, Anthony D. Kelleher, Jing Wen, Chantelle L. Ahlenstiel

Subjects: “…RNA therapeutics…”
Get full text

From Molecular Mechanisms to Therapeutics: Understanding MicroRNA-21 in Cancer by Jiho Rhim, Woosun Baek, Yoona Seo, Jong Heon Kim

Subjects: Get full text

Engineering Cell-Derived Nanovesicles for Targeted Immunomodulation by Adil Ali Sayyed, Piyush Gondaliya, Irene K. Yan, James Carrington, Julia Driscoll, Anuradha Moirangthem, Tushar Patel

Subjects: Get full text